Table 3.
Indication | Number of studies |
---|---|
Immunomodulation | 105 |
Multiple sclerosis/atherosclerosis | 31 |
Type 1 diabetes | 18 |
Crohn's disease | 22 |
Systemic lupus (erythematosus/colitis) | 11 |
Rheumatoid arthritis/Sjögren's syndrome | 7 |
Buerger's disease/sickle cell disease | 3 |
HIV | 2 |
Limbus corneae insufficiency syndrome | 1 |
Periodontitis | 5 |
Progressive hemifacial atrophy | 2 |
Retinitis pigmentosa | 3 |
Graft enhancement | 44 |
GvHD | 41 |
Hematopoietic malignancies | 3 |
All values have been extracted from https://clinicaltrials.gov/.